113 related articles for article (PubMed ID: 9493574)
1. Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia.
Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Thromb Haemost; 1998 Feb; 79(2):268-75. PubMed ID: 9493574
[TBL] [Abstract][Full Text] [Related]
2. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
3. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
Goubran F; Maklady F; Saad M; el-Ashry M
Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
[TBL] [Abstract][Full Text] [Related]
4. Platelet function in hyperlipoproteinaemia.
Parízek M; Parízková M; Kubisz P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):752-9. PubMed ID: 2416652
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
Ravindran R; Krishnan LK
Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and in vivo distribution of in-111-labelled platelets and platelet function in familial hypercholesterolaemia.
Wessels P; Heyns AD; Esterhuysen AJ; Badenhorst PN; Lötter MG; Pieters H; Kotzè HF
Thromb Haemost; 1987 Oct; 58(3):811-6. PubMed ID: 3433247
[TBL] [Abstract][Full Text] [Related]
7. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416
[TBL] [Abstract][Full Text] [Related]
9. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
[TBL] [Abstract][Full Text] [Related]
11. Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers.
Albert J; Wall n NH; Li N; Frostell C; Hjemdahl P
Clin Sci (Lond); 1999 Sep; 97(3):345-53. PubMed ID: 10464060
[TBL] [Abstract][Full Text] [Related]
12. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
[TBL] [Abstract][Full Text] [Related]
13. [Platelet aggregation in hyperlipoproteinemias].
Calabrese S; Da Col PG; Giansante C; Morgante O; Cattin L
Minerva Med; 1982 May; 73(22):1541-6. PubMed ID: 7088380
[TBL] [Abstract][Full Text] [Related]
14. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
[TBL] [Abstract][Full Text] [Related]
15. Increased platelet activity in patients with isolated coronary artery ectasia.
Yasar AS; Erbay AR; Ayaz S; Turhan H; Metin F; Ilkay E; Sabah I
Coron Artery Dis; 2007 Sep; 18(6):451-4. PubMed ID: 17700216
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia.
Davì G; Ganci A; Averna M; Giammarresi C; Barbagallo C; Catalano I; Calà A; Notarbartolo A
Thromb Haemost; 1995 Oct; 74(4):1015-9. PubMed ID: 8560403
[TBL] [Abstract][Full Text] [Related]
17. Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation.
Wallén NH; Goodall AH; Li N; Hjemdahl P
Clin Sci (Lond); 1999 Jul; 97(1):27-35. PubMed ID: 10369791
[TBL] [Abstract][Full Text] [Related]
18. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry.
Labiós M; Martínez M; Gabriel F; Guiral V; Martínez E; Aznar J
Thromb Res; 2005; 115(4):263-70. PubMed ID: 15668185
[TBL] [Abstract][Full Text] [Related]
19. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
20. [Coronary artery reserve in patients with hyperlipoproteinemias (author's transl)].
Kaffarnik H; Braun B; Eltze C; Hausmann L; Mühlfellner G; Mühlfellner O; Neitzert A; Schneider J; Schubotz R; Zehner J
Z Kardiol; 1978 Jul; 67(7):481-6. PubMed ID: 685378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
